Mireille van Westreenen

1.7k total citations
42 papers, 818 citations indexed

About

Mireille van Westreenen is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Molecular Medicine. According to data from OpenAlex, Mireille van Westreenen has authored 42 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Medicine. Recurrent topics in Mireille van Westreenen's work include Antibiotic Resistance in Bacteria (14 papers), Cystic Fibrosis Research Advances (11 papers) and Pneumonia and Respiratory Infections (9 papers). Mireille van Westreenen is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Cystic Fibrosis Research Advances (11 papers) and Pneumonia and Respiratory Infections (9 papers). Mireille van Westreenen collaborates with scholars based in Netherlands, United Kingdom and Canada. Mireille van Westreenen's co-authors include Harm A.W.M. Tiddens, Hettie M. Janssens, Wil H. F. Goessens, Erlangga Yusuf, Johann Pitout, Akke K. van der Bij, Nelianne J. Verkaik, Gisele Peirano, Debby Bogaert and Elisabeth A. M. Sanders and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and PEDIATRICS.

In The Last Decade

Mireille van Westreenen

41 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mireille van Westreenen Netherlands 18 265 254 235 214 148 42 818
Muhammad W. Raza United Kingdom 20 106 0.4× 344 1.4× 101 0.4× 321 1.5× 145 1.0× 33 901
Peter Taylor Australia 12 235 0.9× 214 0.8× 191 0.8× 121 0.6× 95 0.6× 25 740
Assia Ben Hassen Tunisia 15 64 0.2× 346 1.4× 186 0.8× 156 0.7× 175 1.2× 49 847
Suzanne Aebi Switzerland 14 87 0.3× 185 0.7× 165 0.7× 403 1.9× 123 0.8× 18 773
Kelly B. Flett United States 10 85 0.3× 129 0.5× 269 1.1× 131 0.6× 155 1.0× 17 628
V. Keer United Kingdom 11 187 0.7× 169 0.7× 210 0.9× 93 0.4× 238 1.6× 12 661
Liliana Fernández Canigia Argentina 15 55 0.2× 296 1.2× 159 0.7× 259 1.2× 177 1.2× 66 801
Gökhan Aygün Türkiye 13 69 0.3× 428 1.7× 161 0.7× 195 0.9× 207 1.4× 70 815
Mary Crowe United Kingdom 16 199 0.8× 147 0.6× 146 0.6× 186 0.9× 98 0.7× 33 670
Keiji Kanemitsu Japan 15 67 0.3× 166 0.7× 160 0.7× 196 0.9× 231 1.6× 53 731

Countries citing papers authored by Mireille van Westreenen

Since Specialization
Citations

This map shows the geographic impact of Mireille van Westreenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireille van Westreenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireille van Westreenen more than expected).

Fields of papers citing papers by Mireille van Westreenen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mireille van Westreenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireille van Westreenen. The network helps show where Mireille van Westreenen may publish in the future.

Co-authorship network of co-authors of Mireille van Westreenen

This figure shows the co-authorship network connecting the top 25 collaborators of Mireille van Westreenen. A scholar is included among the top collaborators of Mireille van Westreenen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireille van Westreenen. Mireille van Westreenen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aerts, Robina, Katrien Lagrou, Karin van Dijk, et al.. (2025). Multicenter validation of a galactomannan chemiluminescence immunoassay for the diagnosis of pulmonary aspergillosis on serum of patients with hematological disease. Journal of Clinical Microbiology. 63(2). e0105324–e0105324. 1 indexed citations
2.
3.
Verkaik, Nelianne J., Cornelia C. H. Wielders, H. Boer, et al.. (2024). Antimicrobial susceptibility to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients. Microbiology Spectrum. 12(11). e0114224–e0114224. 6 indexed citations
4.
Verkaik, Nelianne J., Cornelia C. H. Wielders, H. Boer, et al.. (2024). O03 Phenotypic antimicrobial resistance to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients. JAC-Antimicrobial Resistance. 6(Supplement_1). 1 indexed citations
5.
Euser, Sjoerd M., Dennis Souverein, Annemarie M. C. van Rossum, et al.. (2024). Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023. Eurosurveillance. 29(4). 26 indexed citations
6.
Sips, Gregorius J., et al.. (2023). Evidence of cat-to-human transmission of Staphylococcus felis. Journal of Medical Microbiology. 72(2). 8 indexed citations
7.
Fluit, Ad C., Jumamurat R. Bayjanov, María Diez‐Aguilar, et al.. (2021). Characterization of clinical Ralstonia strains and their taxonomic position. Antonie van Leeuwenhoek. 114(10). 1721–1733. 28 indexed citations
8.
Kate, Marian T. ten, Rixt A. Wijma, Stefan A. Boers, et al.. (2020). Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia–Septicemia Model in Rats. Antibiotics. 9(3). 109–109. 9 indexed citations
9.
Jong, Carmen C.M. de, Mireille van Westreenen, P Croughs, et al.. (2020). Clinical relevance of Scedosporium spp. and Exophiala dermatitidis in patients with cystic fibrosis: A nationwide study. Medical Mycology. 58(7). 859–866. 22 indexed citations
10.
Mathôt, Ron A. A., Rob Pieters, Válerie de Haas, et al.. (2019). Population Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Prophylaxis in Pediatric Acute Lymphoblastic Leukemia Patients. Clinical Infectious Diseases. 71(8). e281–e288. 5 indexed citations
11.
Visser, Maartje, Mireille van Westreenen, Jan van Bergen, & Birgit van Benthem. (2019). Low gonorrhoea antimicrobial resistance and culture positivity rates in general practice: a pilot study. Sexually Transmitted Infections. 96(3). 220–222. 8 indexed citations
12.
Diez‐Aguilar, María, Miquel B. Ekkelenkamp, María‐Isabel Morosini, et al.. (2018). Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients. International Journal of Antimicrobial Agents. 53(1). 84–88. 29 indexed citations
13.
Mouton, Johan W., et al.. (2017). Patient-specific modelling of regional tobramycin concentration levels in airways of patients with cystic fibrosis: can we dose once daily?. Journal of Antimicrobial Chemotherapy. 72(12). 3435–3442. 12 indexed citations
14.
Prevaes, Sabine M. P. J., Karin M. de Winter‐de Groot, Hettie M. Janssens, et al.. (2015). Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 193(5). 504–515. 101 indexed citations
15.
Boers, Stefan A., et al.. (2014). Whole-genome mapping for high-resolution genotyping of Pseudomonas aeruginosa. Journal of Microbiological Methods. 106. 19–22. 2 indexed citations
16.
Jongste, Johan C. de, Mireille van Westreenen, Peter Merkus, et al.. (2012). Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan. Pediatric Pulmonology. 48(8). 789–796. 40 indexed citations
17.
Bij, Akke K. van der, Gisele Peirano, Juliëtte A. Severin, et al.. (2012). Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clinical Microbiology and Infection. 18(9). E369–E372. 48 indexed citations
18.
Bij, Akke K. van der, Rosa van Mansfeld, Gisele Peirano, et al.. (2011). First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes. International Journal of Antimicrobial Agents. 37(6). 513–518. 39 indexed citations
19.
Westreenen, Mireille van & Harm A.W.M. Tiddens. (2010). New Antimicrobial Strategies in Cystic Fibrosis. Pediatric Drugs. 12(6). 343–352. 17 indexed citations
20.
Westreenen, Mireille van, et al.. (1999). Perioperative Lavage Promotes Intraperitoneal Adhesion in the Rat. European Surgical Research. 31(2). 196–201. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad W. Raza Breakdown of academic impact, for papers by Peter Taylor Breakdown of academic impact, for papers by Assia Ben Hassen Breakdown of academic impact, for papers by Suzanne Aebi Breakdown of academic impact, for papers by Kelly B. Flett Breakdown of academic impact, for papers by V. Keer Breakdown of academic impact, for papers by Liliana Fernández Canigia Breakdown of academic impact, for papers by Gökhan Aygün Breakdown of academic impact, for papers by Mary Crowe Breakdown of academic impact, for papers by Keiji Kanemitsu
Rankless by CCL
2026